Trials / Completed
CompletedNCT02708329
T-provisional Stenting vs Mini-Crush in Chronic Total Occlusions (CTO)
Results of T-provisional and Mini Crush Stenting in Patients With Bifurcation Lesions After Chronic Coronary Arteries Occlusions Recanalization: A Prospective Randomized Single-center Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 146 (actual)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to compare the results of using T-provisional and Mini-Crush stenting techniques in patients with bifurcation lesions in the CTO segment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | T-provisional stenting | Standard endovascular T-provisional stenting technique |
| PROCEDURE | Mini-crush stenting | Standard endovascular Mini-crush stenting technique |
| PROCEDURE | CTO coronary angioplasty | A standard endovascular procedure is carried out under local anesthesia and under fluoroscopic control. Recanalisation of coronary artery CTO is performed by the hydrophilic coronary wire, using the most appropriate technique. Then balloon angioplasty of target lesion is provided. After the angiographic control coronary stent is implanted. After coronary wire removing control angiographic study is provided. Medical therapy includes aspirin(acid acetylsalicylic) 125 - 300 mg/d and plavix(clopidogrel) in dose 300-600 mg prescription before the procedure and heparin (heparin sodium) injection during the procedure(5000 U iv). After the procedure aspirin(acid acetylsalicylic) in dose 100 mg/d within long period should be prescribed in all the patients, and plavix(clopidogrel) in dose 75/d should be prescribed within 12 months. |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-12-01
- Completion
- 2013-12-01
- First posted
- 2016-03-15
- Last updated
- 2016-05-10
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT02708329. Inclusion in this directory is not an endorsement.